Attached files
| file | filename |
|---|---|
| S-1/A - S-1/A - Biostage, Inc. | v334458_s1a.htm |
| EX-21 - SUBSIDIARIES OF THE REGISTRANT - Biostage, Inc. | v334458_ex21.htm |
| EX-10.15 - CONFIDENTIAL TREATMENT REQUESTED - Biostage, Inc. | v334458_ex10-15.htm |
| EX-10.20 - SPONSORED RESEARCH AGREEMENT - Biostage, Inc. | v334458_ex10-20.htm |
| EX-10.22 - NOVEL SURGERY AGREEMENT - Biostage, Inc. | v334458_ex10-22.htm |
| EX-10.18 - PATENT RIGHTS ASSIGNMENT - Biostage, Inc. | v334458_ex10-18.htm |
| EX-10.21 - NOVEL SURGERY AGREEMENT - Biostage, Inc. | v334458_ex10-21.htm |
| EX-10.19 - CONFIDENTIAL TREATMENT REQUESTED - Biostage, Inc. | v334458_ex10-19.htm |
| EX-10.17 - EXHIBIT 10.17 - Biostage, Inc. | v334458_ex10-17.htm |
| EX-10.16 - EXHIBIT 10.16 - Biostage, Inc. | v334458_ex10-16.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Harvard Bioscience, Inc.:
We consent to the use of our report dated December 11, 2012, with respect to the balance sheets of Harvard Apparatus Regenerative Technology, Inc., a business segment of Harvard Bioscience, Inc. and development stage company, as of December 31, 2011 and 2010, and the related statements of operations, invested equity (deficit), and cash flows for the years ended December 31, 2011 and 2010, for the period from February 24, 2009 (inception) to December 31, 2009 and for the period from February 24, 2009 (inception) to December 31, 2011, included herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
Boston, Massachusetts
February 15, 2013